Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

UZ KU Leuven

1 abstract

Abstract
ABATACEPT PROVIDES SIGNIFICANT AND SUSTAINED BENEFITS IN CLINICAL AND PATIENT-REPORTED OUTCOMES THROUGH 2 YRS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO METHOTREXATE (MTX): THE LONG-TERM EXTENSION (LTE) OF THE AIM TRIAL
Org: Albany Medical College, The Center for Rheumatology, University of Leeds, Bristol-Myers Squibb, UZ KU Leuven,